Author

Shruti Patel

Queen Mary University of LondonPrimary ORCID profile (0009-0009-5794-4778 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Shruti PateliD3 papers · Sunnybrook Research Institute

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abigail Tappenden· 1 shared Amit SudiD· 1 shared Aytug Kizilors· 1 shared Bela G. PateliD· 1 shared Claudia Davies· 1 shared Foteini KalampalikaiD· 1 shared John G. GribbeniD· 1 shared John S. BomalaskiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abigail Tappenden

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ASS1 deficiency defines a therapeutic vulnerability in Philadelphia chromosome-positive acute lymphoblastic leukaemia

Michael James Austin, Shruti Patel, Ronas Taner Kesmez, Foteini Kalampalika, Claudia Davies, Amit Sud, Aytug Kizilors, Nicholas C. Lea, Paulo Inocêncio, Abigail Tappenden, Marianne Grantham, John S. Bomalaski, John G. Gribben, Miguel Ganuza, Peter Wojciech Szlosarek, Bela G. Patel

This study identifies ASS1 deficiency as a therapeutic target in Ph+ ALL, showing arginine deprivation induces apoptosis and overcomes TKI resistance.

bioRxiv · May 25, 2026 · PreprintCancer Biology